SIANI, ALFONSO
 Distribuzione geografica
Continente #
AS - Asia 8.056
NA - Nord America 5.740
EU - Europa 1.774
SA - Sud America 1.290
AF - Africa 152
Continente sconosciuto - Info sul continente non disponibili 151
OC - Oceania 13
Totale 17.176
Nazione #
US - Stati Uniti d'America 5.399
SG - Singapore 3.134
CN - Cina 1.872
HK - Hong Kong 1.144
BR - Brasile 987
IT - Italia 727
VN - Vietnam 649
FR - Francia 455
BD - Bangladesh 294
KR - Corea 272
JP - Giappone 176
IN - India 148
CA - Canada 141
GB - Regno Unito 104
NL - Olanda 88
FI - Finlandia 86
AR - Argentina 85
MX - Messico 83
DE - Germania 78
CO - Colombia 76
ID - Indonesia 67
EC - Ecuador 64
ZA - Sudafrica 64
IL - Israele 38
TR - Turchia 31
IQ - Iraq 26
RU - Federazione Russa 26
SA - Arabia Saudita 26
PL - Polonia 23
UA - Ucraina 23
VE - Venezuela 23
EG - Egitto 22
JM - Giamaica 21
PK - Pakistan 21
SE - Svezia 20
AT - Austria 19
JO - Giordania 19
CL - Cile 18
ES - Italia 18
PH - Filippine 18
CR - Costa Rica 17
MY - Malesia 16
PY - Paraguay 15
UZ - Uzbekistan 15
AE - Emirati Arabi Uniti 13
PE - Perù 13
MA - Marocco 12
NI - Nicaragua 12
KE - Kenya 11
TN - Tunisia 11
TT - Trinidad e Tobago 11
AU - Australia 10
BG - Bulgaria 10
CZ - Repubblica Ceca 10
NP - Nepal 10
TH - Thailandia 9
UY - Uruguay 9
AZ - Azerbaigian 8
BB - Barbados 8
HN - Honduras 8
RS - Serbia 8
BE - Belgio 7
DO - Repubblica Dominicana 7
GT - Guatemala 7
TW - Taiwan 7
AL - Albania 6
DZ - Algeria 6
PT - Portogallo 6
BH - Bahrain 5
ET - Etiopia 5
HU - Ungheria 5
LB - Libano 5
PA - Panama 5
RO - Romania 5
CI - Costa d'Avorio 4
EE - Estonia 4
HR - Croazia 4
KZ - Kazakistan 4
LT - Lituania 4
MK - Macedonia 4
OM - Oman 4
PR - Porto Rico 4
SC - Seychelles 4
SI - Slovenia 4
SV - El Salvador 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CH - Svizzera 3
GE - Georgia 3
GR - Grecia 3
IE - Irlanda 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
AO - Angola 2
Totale 16.983
Città #
Singapore 1.905
Hong Kong 1.130
Hefei 874
San Jose 533
Santa Clara 507
Ashburn 448
Lauterbourg 346
Beijing 286
Seoul 271
Ho Chi Minh City 236
Los Angeles 167
Hanoi 155
Tokyo 131
Dallas 129
New York 125
Rome 65
São Paulo 65
Buffalo 64
Bengaluru 61
Milan 60
Naples 59
Chicago 50
Atlanta 49
Helsinki 49
Johannesburg 44
Council Bluffs 40
Rio de Janeiro 39
Brooklyn 38
Minamishinagawa 38
Phoenix 38
Mexico City 34
Montreal 33
Toronto 32
North Charleston 31
Guangzhou 29
Lappeenranta 29
Orem 28
Houston 26
Marigliano 24
Denver 23
Quito 23
Belo Horizonte 21
Bogotá 21
Da Nang 21
Brasília 20
Dhaka 20
Frankfurt am Main 20
Las Vegas 20
San Francisco 20
Shanghai 20
Amman 19
Turin 19
Curitiba 17
Guayaquil 17
Nuremberg 17
Philadelphia 17
San Antonio 17
Washington 17
Haiphong 16
London 16
Guarulhos 15
Hải Dương 15
Boston 14
Detroit 14
San José 14
Thái Nguyên 14
Elk Grove Village 13
Medellín 13
Miami 13
Newark 13
Tashkent 13
The Bronx 13
Warsaw 13
Boardman 12
Bologna 12
Chennai 12
Cincinnati 12
Fortaleza 12
Guebwiller 12
Kingston 12
Orlando 12
Salvador 12
Shenzhen 12
Vienna 12
Avellino 11
Biên Hòa 11
Buenos Aires 11
Campinas 11
Can Tho 11
Hangzhou 11
Managua 11
Charlotte 10
Florence 10
Jakarta 10
Jeddah 10
Louisville 10
Nairobi 10
Nha Trang 10
Stockholm 10
Amsterdam 9
Totale 9.144
Nome #
Safety of astaxanthin for its use as a novel food in food supplements 637
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population representative studies with 141 million participants. 373
Safety of chia seeds (Salvia hispanica L.) as a novel food for extended uses pursuant to Regulation (EU) 2015/2283 347
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 populationrepresentative studies with 222 million children, adolescents, and adults. 309
Affron® and increase in positive mood: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 226
Beta-glucans from oats and/or barley in a ready-to-eat cereal manufactured via pressure cooking and reduction of blood-glucose rise after consumption: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 189
Safety of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of nicotinamide from this source, in the context of Directive 2002/46/EC 105
Diminishing benefits of urban living for children and adolescents' growth and development. 104
SPREAD: Stroke Prevention and Educational Awareness Diffusion (IV Edizione); Ictus cerebrale:linee guida italiane di prevenzione e trattamento. Cap. 7 103
Dietary Advanced Glycation End Products (AGEs) and Urinary Fluorescent AGEs in Children and Adolescents: Findings from the Italian I.Family Project. 95
European Nutritional Guidelines for the Management of Childhood Obesity: The Role of Personalised Nutrition 95
Dietary Diversity and Its Association with Diet Quality, and Health Status of European Children, Adolescents and Adults: Results from the I.Family Study. 94
Correlates of bitter, sweet, salty and umami taste sensitivity in European children: Role of sex, age and weight status - The IDEFICS study 93
Circulating miRNAs Are Associated with Inflammation Biomarkers in Children with Overweight and Obesity: Results of the I.Family Study 93
Plasma microRNA expression profiles are associated with early childhood obesity: results of the I.Family Study 92
Guidance on the scientific requirements for a notification and application for authorisation of traditional foods from third countries in the context of Regulation (EU) 2015/2283 87
Green kiwifruit (lat. Actinidia deliciosa var. Hayward) and maintenance of normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 86
Circulating miR-191 and miR-375 are associated with markers of insulin resistance in overweight /obese children: results of the I.Family Study 84
Development and Validation of a Self-Administered Semiquantitative Food Frequency Questionnaire Focused on Gut Microbiota: The Stance4Health-FFQ 83
Association between Urinary Advanced Glycation End Products and Subclinical Inflammation in Children and Adolescents: Results from the Italian I.Family cohort. 81
Association between Urinary AGEs and Circulating miRNAs in Children and Adolescents with Overweight and Obesity from the Italian I.Family Cohort: A Pilot Study 80
C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease: the IMMIDIET Project. 79
I livelli circolanti di leptina predicono lo sviluppo di sindrome metabolica: follow-up di 8 anni dell Olivetti Prospective Heart Study. 76
Ultra-processed foods consumption and diet quality of European children, adolescents and adults: Results from the I.Family study 76
Cohort-Based Reference Values for Serum Ferritin and Transferrin and Longitudinal Determinants of Iron Status in European Children Aged 3–15 Years 76
Body fat distribution and blood pressure according to IOTF definition of childhood overweight: The ARCA project 75
Glycaemic index and body fat distribution in children: The results of the ARCA project 75
Analysis of Gly40Ser polymorphism of the glucagon receptor (GCGR) gene in different ethnic groups 74
Ethnicity and cardiovascular risk: is chromosome Y guilty? 74
Safety of pea and rice protein fermented by Shiitake (Lentinula edodes) mycelia as a Novel food pursuant to Regulation (EU) 2015/2283 73
Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study 73
Guidance on the scientific requirements for an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283 73
Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint 73
GESTATIONAL WEIGHT GAIN IS AN INDEPENDENT DETERMINANT OF OVERWEIGHT AND OBESITY IN SCHOOLCHILDREN: RESULTS OF THE ITALIAN COHORT OF THE IDEFICS PROJECT 71
Guidance on the preparation and submission of an application for authorisation of a novel food in the context of Regulation (EU) 2015/22831 (Revision 1)2 71
Non-pharmacologic treatment of hypertension 70
SPREAD: Stroke Prevention and Educational Awareness Diffusion (IV Edizione); Ictus cerebrale:linee guida italiane di prevenzione e trattamento ,Cap. 7- Prevenzione primaria 70
Percentile reference values for anthropometric body composition indices in European children from the IDEFICS study. 69
Adherence to the obesity-related lifestyle intervention targets in the IDEFICS study. 68
Aldosterone synthase gene (CYP11B2) C-344T polymorphism, blood pressure and plasma aldosterone levels in a multiethnic population 68
L?allele (-55) del promoter del recettore di clearance dei peptidi natriuretici protegge dallo sviluppo di obesità addominale 68
Tas1r3 and Ucn2 transcript level in peripheral blood cells are associated with sugary and fatty food consumption and with excess of fat accumulation in children. 68
Ultra-Processed Foods Consumption and Metabolic Syndrome in European Children, Adolescents, and Adults: Results from the I.Family Study 68
Condensyl ® and decreases sperm DNA damage which is a risk factor for male infertility: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 67
Family structure and childhood obesity: results of the IDEFICS Project 67
Young children's screen activities, sweet drink consumption and anthropometry: results from a prospective European study 66
Glycaemic index and body fat distribution in children: The results of the ARCA project 66
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. 66
Safety of the extension of use of 2'-fucosyllactose/difucosyllactose (2'-FL/DFL) mixture and lacto-N-tetraose (LNT) as novel foods in food supplements for infants pursuant to Regulation (EU) 2015/2283 65
Alcoholdehydrogenase 3 genotypes influence the beneficial effect of alcohol consumption on inflammation. 65
Circulating miRNAs are associated with sleep duration in children/adolescents: results of the I.Family Study 65
The Stance4Health project: evaluating a smart personalised nutrition service for gut microbiota modulation in normal- and overweight adults, and children with obesity, gluten-related disorders or allergy/intolerance to cow's milk. 65
Safety of the extension of use of 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT) as novel foods in food supplements for infants pursuant to Regulation (EU) 2015/2283 64
Safety of glucosyl hesperidin as a Novel food pursuant to Regulation (EU) 2015/2283 64
Potassium homeostasis, Regulation of 63
Dietary reference values for chloride 63
Interaction between the C(-344)T polymorphism of CYP11B2 and age in the regulation of blood pressure and plasma aldosterone levels: cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study 63
Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97 63
Sleep duration and blood pressure in children: Analysis of the pan-European IDEFICS cohort 62
Safety of pyrroloquinoline quinone disodium salt as a novel food pursuant to Regulation (EC)No 258/97 62
Monitoring contaminants in food chain and their impact on human health. 62
Understanding and preventing childhood obesity and related disorders - IDEFICS: A European multilevel epidemiological approach. 61
Polimorfismo dell HINDIII(+/-) del cromosoma Y, pressione arteriosa e lipidi plasmatici in tre popolazioni europee 61
Rising rural body-mass index is the main driver of the global obesity epidemic in adults 61
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. 61
Tolerable upper intake level for dietary sugars 60
Guidance on scientific principles and data requirements for the safety and relative bioavailability assessment of new micronutrient sources 60
Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population 60
Inflammation and insulin resistance according to body composition in European adolescents: the HELENA study 59
Safety of mung bean protein as a novel food pursuant to Regulation (EU) 2015/2283 59
Safety of dried yellow mealworm (Tenebrio molitor larva) as a novel food pursuant to Regulation (EU) 2015/2283 59
Statement on the safety of EstroG-100(TM) as a novel food pursuant to Regulation (EC) No 258/97 59
Guidance for establishing and applying tolerable upper intake levels for vitamins and essential minerals: Draft for internal testing 59
Safety of an extension of use of oil from Schizochytrium limacinum (strain FCC‐3204) as a novel food pursuant to Regulation (EU) 2015/2283 59
Analysis of the association of leptin and adiponectin concentrations with metabolic syndrome in children: Results from the IDEFICS study 58
Moderate-to-vigorous physical activity modulates the association between serum 25-hydroxyvitamin D and bone stiffness in European children and adolescents 58
Dietary calcium intake and adiposity in children and adolescents: Cross-sectional and longitudinal results from IDEFICS/I.Family cohort 57
Polimorfismo HindIII(+/-) del cromosoma Y, pressione arteriosa e lipidi plasmatici in tre popolazioni europee 56
Safety of 3'-sialyllactose (3'-SL) sodium salt produced by derivative strains of Escherichia coli BL21 (DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283 56
ASSOCIATION BETWEEN ADIPOSITY AND URBANIZATION LEVEL IN CHILDREN: RESULTS OF THE ITALIAN COHORT OF THE IDEFICS PROJECT 56
Physical activity, adiposity and urbanization level in children: Results for the italian cohort of the IDEFICS study 56
Circulating microRNAs are associated with early childhood obesity: results of the I.Family Study. 56
Statement on the safety of taxifolin-rich extract from Dahurian Larch (Larix gmelinii) 56
Nutritional recommendations for the prevention of ischemic stroke. 55
Guidance on the preparation and submission of the notification and application for authorisation of traditional foods from third countries in the context of Regulation (EU) 2015/2283 (Revision 1)1 55
Bifidobacterium animalis subsp. lactis Bi-07 contributes to increasing lactose digestion: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 55
Dietary reference values for sodium 54
Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by HIPP-Werk Georg Hipp OHG (dossier submitted by meyer.science GmbH) 54
Componenti della sindrome metabolica in bambini in età scolare della coorte italiana del progetto IDEFICS 54
Statement on the safety of synthetic L-ergothioneine as a novel food - supplementary dietary exposure and safety assessment for infants and young children, pregnant and breastfeeding women 54
Efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé S.A. in reducing the risk of developing atopic dermatitis 54
ASSOCIATION BETWEEN PHYSICAL FITNESS DEGREE AND ADIPOSITY IN CHILDREN: RESULTS OF THE ITALIAN COHORT OF THE IDEFICS PROJECT 53
Safety of hydroxytyrosol as a novel food pursuant to Regulation (EC) No 258/97 53
Olivetti Heart Study: ruolo della variabilità genetica nel rischio di microalbuminuria. 52
Polygenic risk for obesity and its interaction with lifestyle and sociodemographic factors in European children and adolescents 52
Safety of bovine milk osteopontin as a Novel food pursuant to Regulation (EU) 2015/2283 52
Prevalence of psychosomatic and emotional symptoms in European school-aged children and its relationship with childhood adversities: Results from the IDEFICS study 51
Safety of vitamin D2 mushroom powder as a Novel food pursuant to Regulation (EU) 2015/2283 (NF 2019/1471) 51
The relationship of waist circumference to blood pressure: the Olivetti Heart Study 51
Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by Danone Trading ELN B.V 51
Totale 8.390
Categoria #
all - tutte 62.539
article - articoli 56.025
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.944
Totale 120.508


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202495 0 0 0 0 0 0 0 2 3 45 28 17
2024/20254.065 16 22 351 265 511 81 27 153 104 140 1.264 1.131
2025/20269.366 526 1.055 871 1.151 1.588 243 1.253 579 639 554 404 503
2026/20273.650 928 1.079 1.643 0 0 0 0 0 0 0 0 0
Totale 17.176